In cancer cells, Erk phosphorylates PKM2 (pyruvate kinase M2), an enzyme crucial for glycolysis and metabolic reprogramming.135 Before phosphorylation, PKM2 exists primarily in a less active dimeric form, allowing glycolytic intermediates to be diverted into biosynthetic pathways that support rapid cell growth. Here, PKM is linked to cancer.